A pharmacovigilance study to determine risk of mortality in male and female patients with Alzheimer's disease using Rivastigmine

A pharmacovigilance study to determine risk of mortality in male and female patients with Alzheimer's disease using Rivastigmine

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023.

Библиографические подробности
Главный автор:	Shehab, Habibul Mohsin
Другие авторы:	Yasmin, Hasina
Формат:	Диссертация
Язык:	English
Опубликовано:	Brac University 2024
Предметы:	Pharmacovigilance Rivastigmine Alzheimer's disease Dementia Pharmacoepidemiology. Mortality. Alzheimer's disease.
Online-ссылка:	http://hdl.handle.net/10361/22683

Схожие документы

Gender-specific Rhabdomyolysis risk in Alzheimer’s disease patients receiving memantine: a pharmacovigilance study
по: Tabassum, Nadira
Опубликовано: (2024)

Signal detection of rhabdomyolysis and death for rivastigmine: a pharmacovigilance study
по: Mahee, Sadique Abdal
Опубликовано: (2024)

Efficacy of Rivastigmine in Alzheimer’s disease- A structured seview
по: Alim, Abdul
Опубликовано: (2023)

Signal detection of Rhabdomyolysis and death for galantamine: a pharmacovigilance study
по: Karmaker, Swastika
Опубликовано: (2024)

A pharmacovigilance study on Donepezil: signal detection of rhabdomyolysis and death
по: Jahan, Nusrat
Опубликовано: (2023)

Comprehensive review on importance, challenges and future prospects of nanotechnology and combination therapy for Alzheimer’s disease
по: Ishrat, Nowshin
Опубликовано: (2024)

A pharmacovigilance study on Memantine: signal detection of Rhabdomyolysis and death
по: Bakar, Osama Bin Abu
Опубликовано: (2024)

Knowledge of Alzheimer’s disease and its relationship with attitude towards genetic testing for the disease: a survey of the general public in Bangladesh
по: Chowdhury, Sariya Uzrat
Опубликовано: (2022)

Role of protein’s and future treatment options for Alzheimer’s Disease
по: Islam, Md. Irfath
Опубликовано: (2023)

Review on: Contribution of nutrients to retard the progression of Alzheimer’s disease
по: Saha, Bithi Rani
Опубликовано: (2023)

Alzheimer's disease and marriage : an intimate account /
по: Wright, Lore K.
Опубликовано: (1993)

Progress of finding latent therapeutic activity of vaccine for Alzheimer’s disease
по: Hassan, Md. Muhtaz
Опубликовано: (2020)

Glymphatic system: a pathway for managing endogenous metabolites in CNS
по: Tasneem, Sadia
Опубликовано: (2021)

Bio-similar drug development and accessible drugs in the market for the treatment of Alzheimer's Disease: Current status
по: Tamanna, Mst. Taskia
Опубликовано: (2023)

Emerging therapies of Alzheimer’s disease: a comprehensive review
по: Tasin, Md Abtahi
Опубликовано: (2023)

Biomarkers of Alzheimer’s disease: a hope for early diagnosis
по: Aziz, Farhin
Опубликовано: (2019)

An ambient assisted living system for Alzheimer’s patients
по: Abedin, Minhajul, и др.
Опубликовано: (2023)

Prospective detection methods for Tau protein: an important biomarker for Alzheimer’s disease
по: Afra, Sumaiya
Опубликовано: (2022)

Marine compounds in the treatment of Alzheimer’s disease
по: Parveen, Sanjana
Опубликовано: (2022)

Application of microRNA (miRNA) in Alzheimer’s Disease (AD)
по: Halim, Rabea
Опубликовано: (2022)

Exploring the role of programmed cell death protein 1 in alzheimer’s disease associated autoimmunity
по: Aana, Afsara Sumon
Опубликовано: (2021)

Exploring Alzheimer's disease prediction with XAI in various neural network models
по: Rahman, Quazi Ashikur, и др.
Опубликовано: (2022)

Epigenetic dysregulation in neurodegenerative diseases and potential treatment
по: Mostofa, Golam
Опубликовано: (2022)

Gene editing for neurodegenerative diseases-A review
по: Sharna, Anika Islam
Опубликовано: (2023)

A review on adult neurogenesis in Alzheimer’s disease
по: Akter, Moriam
Опубликовано: (2022)

Potential treatments for epigenetic dysregulation in neurological diseases
по: Zaman, Rubaiyat
Опубликовано: (2024)

A review of comparison on efficacy, safety and cost effectiveness of cholinesterase inhibitors, NMDA antagonists and combination therapy in the treatment of Alzheimer’s disease
по: Haque, Mushfiqul
Опубликовано: (2019)

Federated GAN based biomedical image augmentation and classification for Alzheimer’s disease
по: Roy, Aditya, и др.
Опубликовано: (2023)

Investigating the link between Cardiovascular diseases and neurodegenerative disorders
по: Dey, Manashi
Опубликовано: (2024)

An efficient deep learning approach for detecting Alzheimer’s disease using brain images
по: Sani, Mehedi Hasan, и др.
Опубликовано: (2022)

Anti-alzheimer and antioxidant activity of celastrus paniculatus seed
по: Alam, Badrul, и др.
Опубликовано: (2016)

Role of circular RNA in neurological disease
по: Salsabil, Labiba
Опубликовано: (2024)

Design and evaluation of convolutional neural network for detection of Alzheimer’s disease using MRI data
по: Mahbub, Riasat, и др.
Опубликовано: (2022)

Skeleton /
по: Parkin, Peter

A review on interrelation among post-authorisation study, regulatory action and pharmacogenetics in pharmacovigilance
по: Nusrat, Tanzina
Опубликовано: (2019)

হার্ট, ব্লাড, ফুড /
по: কাসেম, এম এ

Antihypertensive drugs and risk of cancer: A pharmacovigilance study
по: Rahman, Ahadina
Опубликовано: (2018)

Management of Diabetes patients during COVID-19
по: Pantho, G. M. Golam Mehebub
Опубликовано: (2021)

Pharmacoepidemiology and pharmacovigilance : synergistic tools to better Investigate drug safety /
по: Nour, Sabrina
Опубликовано: (2019)

Detection of alzheimer's disease using deep learning
по: Hasan, Mahmudul, и др.
Опубликовано: (2021)